Market Research Forecasts Urological Disorders Market at $10.3 Billion by 2017
(firmenpresse) - ROCKVILLE, MD -- (Marketwire) -- 04/03/12 -- MarketResearch.com has announced the addition of the new report "Urological Disorders Therapeutics to 2017 - Large Number of Licensing Deals for Approved Products Reflects a Pessimistic R&D Future," to their collection of Urology market reports. For more information, visit
The global urological disorders market is growing rapidly with the increasing Benign Prostatic Hyperplasia (BPH) and Urinary Tract Infection (UTI) diseased populations. In 2010, the global urological disorders market was estimated to be worth $8.1 billion, representing a CAGR of 7.9% between 2002 and 2010. The BPH market, with sales worth $4.1 billion in 2010, accounted for 50% of the total urological disorders market. The UI market was estimated to be $2.4 billion, the second largest urological disorders market, and to have grown at a CAGR of 6.2% between 2002 and 2010. By 2017, the global urological disorders market is forecast to be worth $10.3 billion, representing a CAGR of 3.4% between 2010 and 2017. BPH is expected to remain the largest market in the urological disorders segment with sales of $5.7 billion in 2017. The Research and Development (R&D) pipeline for urological disorders currently has 72 molecules in different stages of clinical development. The BPH R&D pipeline accounted for approximately 39% of the total urological disorders pipeline.
The global urological disorders market is very competitive, with the top five companies accounting for 88% of the total market in 2010. Johnson & Johnson leads the market with a share of 29%. Its two main drugs are Levaquin and Elmiron, which have strong presence in the UTI and Urinary Incontinence (UI) markets respectively.
The urological disorders market has witnessed strong deal activity between 2004 and 2011. The 120 deals conducted comprised M&A deals (44), licensing deals (67) and co-development deals (nine). This growth has driven M&A activities, primarily for companies looking to expand their product portfolio for indications such as BPH, UI, UTI and Interstitial Cystitis (IC).
The urological disorders market remains attractive and is set to see moderate growth between 2010 and 2017, despite many of its blockbuster drugs going off-patent during the period.
For more information, visit
MarketResearch.com is the leading provider of global market intelligence products and services. With research reports from more than 720 top consulting and advisory firms, MarketResearch.com offers instant online access to the world's most extensive database of expert insights on global industries, companies, products, and trends. Moreover, MarketResearch.com's Research Specialists have in-depth knowledge of the publishers and the various types of reports in their respective industries and are ready to provide research assistance. For more information, call Veronica Franco at 240-747-3016 or visit .
Contact:
Veronica Franco
MarketResearch.com
240.747.3016
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 03.04.2012 - 08:08 Uhr
Sprache: Deutsch
News-ID 131302
Anzahl Zeichen: 0
contact information:
Town:
ROCKVILLE, MD
Kategorie:
Internet
Diese Pressemitteilung wurde bisher 244 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Market Research Forecasts Urological Disorders Market at $10.3 Billion by 2017"
steht unter der journalistisch-redaktionellen Verantwortung von
MarketResearch.com (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
